Skip to content
★ Sign in to follow
UK

Uday Kompella

Board Director
Director
Total declarations
18
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (14 ops.)
€7.1M

Latest filing published 03 Nov 2021 for Ocugen, Inc., €345k.

Filing timeline

BuySale
Uday Kompella

Insider track record

Disclosed buys
0
Disclosed sells
14
Signal history

Uday Kompella: trading record in brief

All filings by Uday Kompella on record concern Ocugen, Inc., in the capacity of board member. We count 18 filings; the first trade dates from 26 April 2021 and the latest from 2 November 2021.

On the market, this insider has only sold: 14 sales, €7.1M in total. Outside the open market, there are 4 option exercises.

The record was last updated on 3 November 2021 with an open-market sale (€345k) in Ocugen, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Uday Kompella

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations18 total
  • ▼
    DirectorExecutivesOcugen, Inc.
    400,250 USD29SEC
    25,000 shares@ US$16.014.8% of flowCommon StockSEC:0001891015-21-000011:1
  • ▼
    DirectorExecutivesOcugen, Inc.
    351,250 USD30SEC
    25,000 shares@ US$14.0513.9% of flowCommon StockSEC:0001891015-21-000011:0
  • ▼
    DirectorExecutivesOcugen, Inc.
    301,250 USD29SEC
    25,000 shares@ US$12.053.6% of flowCommon StockSEC:0001192482-21-000746:1
  • ▼
    DirectorExecutivesOcugen, Inc.
    421,049 USD25SEC
    46,371 shares@ US$9.0816.6% of flowCommon StockSEC:0001192482-21-000746:0
  • ▼
    DirectorExecutivesOcugen, Inc.
    17,101 USD11SEC
    1,898 shares@ US$9.010.7% of flowCommon StockSEC:0001882178-21-000034:0
  • ▼
    DirectorExecutivesOcugen, Inc.
    15,614 USD29SEC
    1,731 shares@ US$9.020.2% of flowCommon StockSEC:0001879785-21-000010:1
  • ▼
    DirectorExecutivesOcugen, Inc.
    2M USD18SEC
    200,000 shares@ US$8.4166.4% of flowCommon StockSEC:0001879785-21-000010:0
  • ▼
    DirectorExecutivesOcugen, Inc.
    68,100 USD26SEC
    10,000 shares@ US$6.810.8% of flowCommon StockSEC:0001192482-21-000639:1
  • ◇
    DirectorExecutivesOcugen, Inc.
    18,300 USD11SEC
    10,000 shares@ US$1.830.7% of flowCommon StockSEC:0001192482-21-000639:0
  • ▼
    DirectorExecutivesOcugen, Inc.
    81,300 USD29SEC
    10,000 shares@ US$8.130.9% of flowCommon StockSEC:0001192482-21-000575:1
  • ◇
    DirectorExecutivesOcugen, Inc.
    18,300 USD11SEC
    10,000 shares@ US$1.830.7% of flowCommon StockSEC:0001192482-21-000575:0
  • ▼
    DirectorExecutivesOcugen, Inc.
    63,425 USD29SEC
    7,191 shares@ US$8.820.7% of flowCommon StockSEC:0001192482-21-000472:1
  • ◇
    DirectorExecutivesOcugen, Inc.
    13,519 USD11SEC
    7,191 shares@ US$1.880.5% of flowCommon StockSEC:0001192482-21-000472:0
  • ▼
    DirectorExecutivesOcugen, Inc.
    231,200 USD29SEC
    20,000 shares@ US$11.562.7% of flowCommon StockSEC:0001192482-21-000393:1
  • ▼
    DirectorExecutivesOcugen, Inc.
    350,000 USD29SEC
    25,000 shares@ US$14.004.0% of flowCommon StockSEC:0001192482-21-000393:2
  • ▼
    DirectorExecutivesOcugen, Inc.
    400,500 USD29SEC
    25,000 shares@ US$16.024.6% of flowCommon StockSEC:0001192482-21-000393:3
  • ◇
    DirectorExecutivesOcugen, Inc.
    10,200 USD11SEC
    20,000 shares@ US$0.510.4% of flowCommon StockSEC:0001192482-21-000393:0
  • ▼
    DirectorExecutivesOcugen, Inc.
    4M USD28SEC
    350,000 shares@ US$11.7047.2% of flowCommon StockSEC:0001192482-21-000371:0

18 of 18 declarations